Ozempic's list price once topped $935 per month. For millions of uninsured Americans, that number ended the conversation before it began. But in 2026, the landscape shifted — and most patients don't know it yet.
Novo Nordisk cut the self-pay price of Ozempic and Wegovy to $349 per month for patients who pay out of pocket, and Eli Lilly made Zepbound (tirzepatide) available directly for $499/month through its LillyDirect platform. These aren't coupons or promotions — they're new baseline prices.
Here's what that actually means for you, and how to get the lowest possible price.
What Changed and Why
The price cuts came under pressure from the Trump administration's executive order directing pharmaceutical companies to lower drug costs. Novo Nordisk agreed to cap self-pay Ozempic and Wegovy at $349/month; Eli Lilly followed with tirzepatide pricing through LillyDirect.
These deals apply specifically to self-pay patients — people without insurance coverage for GLP-1 medications, or whose insurance doesn't cover them. If your insurance covers Ozempic, these prices don't apply to you (your copay structure does).
Step 1: Confirm You're Getting the New Price
Ask your pharmacy directly: "What is the cash-pay price for Ozempic [or Wegovy] under the Novo Nordisk self-pay program?" If they don't know what you're talking about, try a different pharmacy or call Novo Nordisk's customer line at 1-833-NOVO-411.
Not every pharmacy has updated its pricing. Large chain pharmacies (CVS, Walgreens, Walmart) are more likely to have the new rate on file.
Step 2: Check the NovoCare Patient Assistance Program First
Before paying even $349/month, check whether you qualify for Novo Nordisk's NovoCare Patient Assistance Program (PAP), which provides Ozempic and Wegovy at no cost for patients who meet income eligibility requirements.
General eligibility guidelines (confirm current terms at novocare.com, as they change):
- Income: Household income at or below approximately 400% of the Federal Poverty Level (~$60,240 for a single person in 2026)
- Insurance: Uninsured, or insured but with inadequate coverage
- Valid prescription from a licensed provider
- No Medicare or Medicaid (separate programs apply — see below)
If you qualify for the PAP, you pay nothing. The medication ships directly to you or your pharmacy.
Step 3: If You Have Medicare
The NovoCare savings card is not available to Medicare patients — federal law prohibits it. But two things changed in 2026 that help:
- Medicare GLP-1 Bridge Program: Starting July 1, 2026, a CMS demonstration program caps GLP-1 copays at $50/month for qualifying Medicare Part D beneficiaries for diabetes management.
- Extra Help / Low Income Subsidy: If your income and assets are limited, this federal program can significantly reduce Part D costs across the board.
Contact your Part D plan or call 1-800-MEDICARE to find out if you qualify for Extra Help.
Step 4: Stack with GoodRx (for Commercially Insured Patients Without GLP-1 Coverage)
If you're commercially insured but your plan doesn't cover Ozempic, GoodRx sometimes offers prices competitive with the new self-pay rate — and Amazon Pharmacy now auto-applies manufacturer coupons at checkout, which can reduce costs further.
Run a GoodRx search for your specific dose and quantity to compare before filling.
What If $349/Month Is Still Too Much?
That's a fair position — $4,188/year is still a significant expense. If the self-pay price and NovoCare PAP still don't solve it:
- ClariMeds can check your eligibility across every applicable assistance program simultaneously. Many patients qualify for programs they've never heard of, including state pharmaceutical assistance programs and specialty patient advocacy funds.
- Ask your prescriber about therapeutic alternatives: depending on why you've been prescribed a GLP-1, there may be lower-cost options in the same drug class worth discussing.
Check your eligibility — it takes about 5 minutes
This article contains financial and program access information only. ClariMeds does not provide medical advice. Consult your doctor or pharmacist for clinical questions about Ozempic or any GLP-1 medication.